The global market for Anti-erectile Dysfunction (ED) Drugs was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Anti-erectile Dysfunction (ED) Drugs, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Anti-erectile Dysfunction (ED) Drugs by region & country, by Type, and by Application.

The Anti-erectile Dysfunction (ED) Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-erectile Dysfunction (ED) Drugs.

Market Segmentation

Scope of Anti-erectile Dysfunction (ED) Drugs - Market Report

Report Metric	Details
Report Name	Anti-erectile Dysfunction (ED) Drugs - Market
CAGR	5%
Segment by Type:	Sildenafil (Viagra) Vardenafil (Levitra, Staxyn) Tadalafil (Cialis) Avanafil (Stendra) Udenafil (Zydena) Others
Segment by Application	Hospital Retail Pharmacy Clinic Online Pharmacy
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Vivus, Inc., Lilly ICOS LLC, Pfizer, Bayer, Hims, Menarini Group, Lupin, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, General Factory, CSBio, Dong-A ST, Metuchen Pharma, Seoul Pharma, Teva Pharma, S.K. Chemicals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Anti-erectile Dysfunction (ED) Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Anti-erectile Dysfunction (ED) Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Anti-erectile Dysfunction (ED) Drugs in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Anti-erectile Dysfunction (ED) Drugs - Market report?

Ans: The main players in the Anti-erectile Dysfunction (ED) Drugs - Market are Vivus, Inc., Lilly ICOS LLC, Pfizer, Bayer, Hims, Menarini Group, Lupin, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd, General Factory, CSBio, Dong-A ST, Metuchen Pharma, Seoul Pharma, Teva Pharma, S.K. Chemicals

What are the Application segmentation covered in the Anti-erectile Dysfunction (ED) Drugs - Market report?

Ans: The Applications covered in the Anti-erectile Dysfunction (ED) Drugs - Market report are Hospital, Retail Pharmacy, Clinic, Online Pharmacy

What are the Type segmentation covered in the Anti-erectile Dysfunction (ED) Drugs - Market report?

Ans: The Types covered in the Anti-erectile Dysfunction (ED) Drugs - Market report are Sildenafil (Viagra), Vardenafil (Levitra, Staxyn), Tadalafil (Cialis), Avanafil (Stendra), Udenafil (Zydena), Others

1 Market Overview

1.1 Anti-erectile Dysfunction (ED) Drugs Product Introduction

1.2 Global Anti-erectile Dysfunction (ED) Drugs Market Size Forecast

1.2.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Value (2019-2030)

1.2.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume (2019-2030)

1.2.3 Global Anti-erectile Dysfunction (ED) Drugs Sales Price (2019-2030)

1.3 Anti-erectile Dysfunction (ED) Drugs Market Trends & Drivers

1.3.1 Anti-erectile Dysfunction (ED) Drugs Industry Trends

1.3.2 Anti-erectile Dysfunction (ED) Drugs Market Drivers & Opportunity

1.3.3 Anti-erectile Dysfunction (ED) Drugs Market Challenges

1.3.4 Anti-erectile Dysfunction (ED) Drugs Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Anti-erectile Dysfunction (ED) Drugs Players Revenue Ranking (2023)

2.2 Global Anti-erectile Dysfunction (ED) Drugs Revenue by Company (2019-2024)

2.3 Global Anti-erectile Dysfunction (ED) Drugs Players Sales Volume Ranking (2023)

2.4 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Company Players (2019-2024)

2.5 Global Anti-erectile Dysfunction (ED) Drugs Average Price by Company (2019-2024)

2.6 Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Anti-erectile Dysfunction (ED) Drugs

2.9 Anti-erectile Dysfunction (ED) Drugs Market Competitive Analysis

2.9.1 Anti-erectile Dysfunction (ED) Drugs Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Anti-erectile Dysfunction (ED) Drugs Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-erectile Dysfunction (ED) Drugs as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 Sildenafil (Viagra)

3.1.2 Vardenafil (Levitra, Staxyn)

3.1.3 Tadalafil (Cialis)

3.1.4 Avanafil (Stendra)

3.1.5 Udenafil (Zydena)

3.1.6 Others

3.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Type

3.2.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Value, by Type (2019-2030)

3.2.3 Global Anti-erectile Dysfunction (ED) Drugs Sales Value, by Type (%) (2019-2030)

3.3 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Type

3.3.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume, by Type (2019-2030)

3.3.3 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume, by Type (%) (2019-2030)

3.4 Global Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Retail Pharmacy

4.1.3 Clinic

4.1.4 Online Pharmacy

4.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Application

4.2.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Value, by Application (2019-2030)

4.2.3 Global Anti-erectile Dysfunction (ED) Drugs Sales Value, by Application (%) (2019-2030)

4.3 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Application

4.3.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume, by Application (2019-2030)

4.3.3 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume, by Application (%) (2019-2030)

4.4 Global Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Region

5.1.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Region (2019-2024)

5.1.3 Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Region (2025-2030)

5.1.4 Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Region (%), (2019-2030)

5.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Region

5.2.1 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Region (2019-2024)

5.2.3 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Region (2025-2030)

5.2.4 Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Region (%), (2019-2030)

5.3 Global Anti-erectile Dysfunction (ED) Drugs Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

5.4.2 North America Anti-erectile Dysfunction (ED) Drugs Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

5.5.2 Europe Anti-erectile Dysfunction (ED) Drugs Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

5.6.2 Asia Pacific Anti-erectile Dysfunction (ED) Drugs Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

5.7.2 South America Anti-erectile Dysfunction (ED) Drugs Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

5.8.2 Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Anti-erectile Dysfunction (ED) Drugs Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Anti-erectile Dysfunction (ED) Drugs Sales Value

6.2.1 Key Countries/Regions Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

6.2.2 Key Countries/Regions Anti-erectile Dysfunction (ED) Drugs Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

6.3.2 United States Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Anti-erectile Dysfunction (ED) Drugs Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

6.4.2 Europe Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Anti-erectile Dysfunction (ED) Drugs Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

6.5.2 China Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

6.5.3 China Anti-erectile Dysfunction (ED) Drugs Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

6.6.2 Japan Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Anti-erectile Dysfunction (ED) Drugs Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

6.7.2 South Korea Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Anti-erectile Dysfunction (ED) Drugs Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

6.8.2 Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019-2030

6.9.2 India Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

6.9.3 India Anti-erectile Dysfunction (ED) Drugs Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Vivus, Inc.

7.1.1 Vivus, Inc. Company Information

7.1.2 Vivus, Inc. Introduction and Business Overview

7.1.3 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.1.5 Vivus, Inc. Recent Development

7.2 Lilly ICOS LLC

7.2.1 Lilly ICOS LLC Company Information

7.2.2 Lilly ICOS LLC Introduction and Business Overview

7.2.3 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.2.5 Lilly ICOS LLC Recent Development

7.3 Pfizer

7.3.1 Pfizer Company Information

7.3.2 Pfizer Introduction and Business Overview

7.3.3 Pfizer Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Pfizer Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.3.5 Pfizer Recent Development

7.4 Bayer

7.4.1 Bayer Company Information

7.4.2 Bayer Introduction and Business Overview

7.4.3 Bayer Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Bayer Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.4.5 Bayer Recent Development

7.5 Hims

7.5.1 Hims Company Information

7.5.2 Hims Introduction and Business Overview

7.5.3 Hims Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Hims Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.5.5 Hims Recent Development

7.6 Menarini Group

7.6.1 Menarini Group Company Information

7.6.2 Menarini Group Introduction and Business Overview

7.6.3 Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Menarini Group Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.6.5 Menarini Group Recent Development

7.7 Lupin

7.7.1 Lupin Company Information

7.7.2 Lupin Introduction and Business Overview

7.7.3 Lupin Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Lupin Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.7.5 Lupin Recent Development

7.8 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

7.8.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information

7.8.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Introduction and Business Overview

7.8.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.8.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.8.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Development

7.9 General Factory

7.9.1 General Factory Company Information

7.9.2 General Factory Introduction and Business Overview

7.9.3 General Factory Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.9.4 General Factory Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.9.5 General Factory Recent Development

7.10 CSBio

7.10.1 CSBio Company Information

7.10.2 CSBio Introduction and Business Overview

7.10.3 CSBio Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.10.4 CSBio Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.10.5 CSBio Recent Development

7.11 Dong-A ST

7.11.1 Dong-A ST Company Information

7.11.2 Dong-A ST Introduction and Business Overview

7.11.3 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.11.4 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.11.5 Dong-A ST Recent Development

7.12 Metuchen Pharma

7.12.1 Metuchen Pharma Company Information

7.12.2 Metuchen Pharma Introduction and Business Overview

7.12.3 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.12.4 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.12.5 Metuchen Pharma Recent Development

7.13 Seoul Pharma

7.13.1 Seoul Pharma Company Information

7.13.2 Seoul Pharma Introduction and Business Overview

7.13.3 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.13.4 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.13.5 Seoul Pharma Recent Development

7.14 Teva Pharma

7.14.1 Teva Pharma Company Information

7.14.2 Teva Pharma Introduction and Business Overview

7.14.3 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.14.4 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.14.5 Teva Pharma Recent Development

7.15 S.K. Chemicals

7.15.1 S.K. Chemicals Company Information

7.15.2 S.K. Chemicals Introduction and Business Overview

7.15.3 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales, Revenue and Gross Margin (2019-2024)

7.15.4 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product Offerings

7.15.5 S.K. Chemicals Recent Development

8 Industry Chain Analysis

8.1 Anti-erectile Dysfunction (ED) Drugs Industrial Chain

8.2 Anti-erectile Dysfunction (ED) Drugs Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Anti-erectile Dysfunction (ED) Drugs Sales Model

8.5.2 Sales Channel

8.5.3 Anti-erectile Dysfunction (ED) Drugs Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

List of Tables

Table 1. Anti-erectile Dysfunction (ED) Drugs Market Trends

Table 2. Anti-erectile Dysfunction (ED) Drugs Market Drivers & Opportunity

Table 3. Anti-erectile Dysfunction (ED) Drugs Market Challenges

Table 4. Anti-erectile Dysfunction (ED) Drugs Market Restraints

Table 5. Global Anti-erectile Dysfunction (ED) Drugs Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Anti-erectile Dysfunction (ED) Drugs Revenue Market Share by Company (2019-2024)

Table 7. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Anti-erectile Dysfunction (ED) Drugs Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Anti-erectile Dysfunction (ED) Drugs Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Anti-erectile Dysfunction (ED) Drugs

Table 13. Global Anti-erectile Dysfunction (ED) Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-erectile Dysfunction (ED) Drugs as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Anti-erectile Dysfunction (ED) Drugs Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Anti-erectile Dysfunction (ED) Drugs Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Anti-erectile Dysfunction (ED) Drugs Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Anti-erectile Dysfunction (ED) Drugs Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Anti-erectile Dysfunction (ED) Drugs Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Region (2019-2024) & (%)

Table 44. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Region (2025-2030) & (%)

Table 45. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Region (2019-2024) & (%)

Table 49. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Region (2025-2030) & (%)

Table 50. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Anti-erectile Dysfunction (ED) Drugs Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Anti-erectile Dysfunction (ED) Drugs Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Anti-erectile Dysfunction (ED) Drugs Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Anti-erectile Dysfunction (ED) Drugs Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Anti-erectile Dysfunction (ED) Drugs Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Anti-erectile Dysfunction (ED) Drugs Sales Volume, (2025-2030) & (K Units)

Table 57. Vivus, Inc. Company Information

Table 58. Vivus, Inc. Introduction and Business Overview

Table 59. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 61. Vivus, Inc. Recent Development

Table 62. Lilly ICOS LLC Company Information

Table 63. Lilly ICOS LLC Introduction and Business Overview

Table 64. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 66. Lilly ICOS LLC Recent Development

Table 67. Pfizer Company Information

Table 68. Pfizer Introduction and Business Overview

Table 69. Pfizer Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. Pfizer Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 71. Pfizer Recent Development

Table 72. Bayer Company Information

Table 73. Bayer Introduction and Business Overview

Table 74. Bayer Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. Bayer Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 76. Bayer Recent Development

Table 77. Hims Company Information

Table 78. Hims Introduction and Business Overview

Table 79. Hims Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Hims Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 81. Hims Recent Development

Table 82. Menarini Group Company Information

Table 83. Menarini Group Introduction and Business Overview

Table 84. Menarini Group Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Menarini Group Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 86. Menarini Group Recent Development

Table 87. Lupin Company Information

Table 88. Lupin Introduction and Business Overview

Table 89. Lupin Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Lupin Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 91. Lupin Recent Development

Table 92. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Company Information

Table 93. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Introduction and Business Overview

Table 94. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 95. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 96. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Development

Table 97. General Factory Company Information

Table 98. General Factory Introduction and Business Overview

Table 99. General Factory Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 100. General Factory Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 101. General Factory Recent Development

Table 102. CSBio Company Information

Table 103. CSBio Introduction and Business Overview

Table 104. CSBio Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 105. CSBio Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 106. CSBio Recent Development

Table 107. Dong-A ST Company Information

Table 108. Dong-A ST Introduction and Business Overview

Table 109. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 111. Dong-A ST Recent Development

Table 112. Metuchen Pharma Company Information

Table 113. Metuchen Pharma Introduction and Business Overview

Table 114. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 116. Metuchen Pharma Recent Development

Table 117. Seoul Pharma Company Information

Table 118. Seoul Pharma Introduction and Business Overview

Table 119. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 120. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 121. Seoul Pharma Recent Development

Table 122. Teva Pharma Company Information

Table 123. Teva Pharma Introduction and Business Overview

Table 124. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 125. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 126. Teva Pharma Recent Development

Table 127. S.K. Chemicals Company Information

Table 128. S.K. Chemicals Introduction and Business Overview

Table 129. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 130. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product Offerings

Table 131. S.K. Chemicals Recent Development

Table 132. Key Raw Materials Lists

Table 133. Raw Materials Key Suppliers Lists

Table 134. Anti-erectile Dysfunction (ED) Drugs Downstream Customers

Table 135. Anti-erectile Dysfunction (ED) Drugs Distributors List

Table 136. Research Programs/Design for This Report

Table 137. Key Data Information from Secondary Sources

Table 138. Key Data Information from Primary Sources

List of Figures

Figure 1. Anti-erectile Dysfunction (ED) Drugs Product Picture

Figure 2. Global Anti-erectile Dysfunction (ED) Drugs Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Anti-erectile Dysfunction (ED) Drugs Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume (2019-2030) & (K Units)

Figure 5. Global Anti-erectile Dysfunction (ED) Drugs Sales Price (2019-2030) & (US$/Unit)

Figure 6. Anti-erectile Dysfunction (ED) Drugs Report Years Considered

Figure 7. Global Anti-erectile Dysfunction (ED) Drugs Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Anti-erectile Dysfunction (ED) Drugs Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Anti-erectile Dysfunction (ED) Drugs Revenue in 2023

Figure 10. Anti-erectile Dysfunction (ED) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. Sildenafil (Viagra) Picture

Figure 12. Vardenafil (Levitra, Staxyn) Picture

Figure 13. Tadalafil (Cialis) Picture

Figure 14. Avanafil (Stendra) Picture

Figure 15. Udenafil (Zydena) Picture

Figure 16. Others Picture

Figure 17. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 18. Global Anti-erectile Dysfunction (ED) Drugs Sales Value Market Share by Type, 2023 & 2030

Figure 19. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 20. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share by Type, 2023 & 2030

Figure 21. Global Anti-erectile Dysfunction (ED) Drugs Price by Type (2019-2030) & (US$/Unit)

Figure 22. Product Picture of Hospital

Figure 23. Product Picture of Retail Pharmacy

Figure 24. Product Picture of Clinic

Figure 25. Product Picture of Online Pharmacy

Figure 26. Global Anti-erectile Dysfunction (ED) Drugs Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 27. Global Anti-erectile Dysfunction (ED) Drugs Sales Value Market Share by Application, 2023 & 2030

Figure 28. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 29. Global Anti-erectile Dysfunction (ED) Drugs Sales Volume Market Share by Application, 2023 & 2030

Figure 30. Global Anti-erectile Dysfunction (ED) Drugs Price by Application (2019-2030) & (US$/Unit)

Figure 31. North America Anti-erectile Dysfunction (ED) Drugs Sales Value (2019-2030) & (US$ Million)

Figure 32. North America Anti-erectile Dysfunction (ED) Drugs Sales Value by Country (%), 2023 VS 2030

Figure 33. Europe Anti-erectile Dysfunction (ED) Drugs Sales Value (2019-2030) & (US$ Million)

Figure 34. Europe Anti-erectile Dysfunction (ED) Drugs Sales Value by Country (%), 2023 VS 2030

Figure 35. Asia Pacific Anti-erectile Dysfunction (ED) Drugs Sales Value (2019-2030) & (US$ Million)

Figure 36. Asia Pacific Anti-erectile Dysfunction (ED) Drugs Sales Value by Country (%), 2023 VS 2030

Figure 37. South America Anti-erectile Dysfunction (ED) Drugs Sales Value (2019-2030) & (US$ Million)

Figure 38. South America Anti-erectile Dysfunction (ED) Drugs Sales Value by Country (%), 2023 VS 2030

Figure 39. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Value (2019-2030) & (US$ Million)

Figure 40. Middle East & Africa Anti-erectile Dysfunction (ED) Drugs Sales Value by Country (%), 2023 VS 2030

Figure 41. Key Countries/Regions Anti-erectile Dysfunction (ED) Drugs Sales Value (%), (2019-2030)

Figure 42. Key Countries/Regions Anti-erectile Dysfunction (ED) Drugs Sales Volume (%), (2019-2030)

Figure 43. United States Anti-erectile Dysfunction (ED) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 44. United States Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 45. United States Anti-erectile Dysfunction (ED) Drugs Sales Value by Application (%), 2023 VS 2030

Figure 46. Europe Anti-erectile Dysfunction (ED) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 47. Europe Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 48. Europe Anti-erectile Dysfunction (ED) Drugs Sales Value by Application (%), 2023 VS 2030

Figure 49. China Anti-erectile Dysfunction (ED) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 50. China Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 51. China Anti-erectile Dysfunction (ED) Drugs Sales Value by Application (%), 2023 VS 2030

Figure 52. Japan Anti-erectile Dysfunction (ED) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 53. Japan Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 54. Japan Anti-erectile Dysfunction (ED) Drugs Sales Value by Application (%), 2023 VS 2030

Figure 55. South Korea Anti-erectile Dysfunction (ED) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 56. South Korea Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 57. South Korea Anti-erectile Dysfunction (ED) Drugs Sales Value by Application (%), 2023 VS 2030

Figure 58. Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 59. Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 60. Southeast Asia Anti-erectile Dysfunction (ED) Drugs Sales Value by Application (%), 2023 VS 2030

Figure 61. India Anti-erectile Dysfunction (ED) Drugs Sales Value, (2019-2030) & (US$ Million)

Figure 62. India Anti-erectile Dysfunction (ED) Drugs Sales Value by Type (%), 2023 VS 2030

Figure 63. India Anti-erectile Dysfunction (ED) Drugs Sales Value by Application (%), 2023 VS 2030

Figure 64. Anti-erectile Dysfunction (ED) Drugs Industrial Chain

Figure 65. Anti-erectile Dysfunction (ED) Drugs Manufacturing Cost Structure

Figure 66. Channels of Distribution (Direct Sales, and Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions